Who
An van Es-Johansson
Director
Company insider
Files Form 4 as: Director, Cerenome; Director, Savara; Director, Lumos Pharma.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 20 Dec 2019
- Last trade
- 1 Oct 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —921 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —921 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —922 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —922 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —922 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —922 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,686 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,686 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,686 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,686 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | SVRA SavaraBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 13 Aug 2025filed 15 Aug 2025 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —297,794 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —40,122 at $0.00 | filing |
| 12 Dec 2024filed 16 Dec 2024 | SVRA SavaraBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 12 Dec 2024filed 13 Dec 2024 | Lumos Pharmaoption or derivative | SEC FORM 4 Code D | —3,345 | filing |
| 12 Dec 2024filed 13 Dec 2024 | Lumos Pharmaoption or derivative | SEC FORM 4 Code D | —3,328 | filing |
| 12 Dec 2024filed 13 Dec 2024 | Lumos Pharmaoption or derivative | SEC FORM 4 Code D | —3,431 | filing |
| 12 Dec 2024filed 13 Dec 2024 | Lumos Pharmaoption or derivative | SEC FORM 4 Code D | —2,910 | filing |
| 12 Dec 2024filed 13 Dec 2024 | Lumos Pharmaoption or derivative | SEC FORM 4 Code D | —5,729 | filing |
| 12 Dec 2024filed 13 Dec 2024 | Lumos Pharma | SEC FORM 4 Code D | —1,100 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.